FDA considers a material to generally be "approved for investigation as a new drug" whether it is the topic of the Investigational New Drug application (IND) which has long gone into result. Beneath FDA’s rules (21 CFR 312.two), Except if a clinical investigation meets the minimal criteria in that regulation, https://autoaccidentlegalhelp26033.blogdemls.com/32955038/getting-my-full-spectrum-cannabis-to-work